Galera Therapeutics (GRTX) Insider Trading & Ownership → Urgent: They're Coming for Your Retirement Money Next! (From Lear Capital) (Ad) Free GRTX Stock Alerts $0.20 +0.01 (+5.40%) (As of 05/16/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Galera Therapeutics (NASDAQ:GRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.90%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$444,950.00Number OfInsiders Selling(Last 3 Years)0 Get GRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Galera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GRTX Insider Buying and Selling by Quarter Ad Lear CapitalUrgent: They're Coming for Your Retirement Money Next!According to this data from the US Census Bureau it's possible that by 2040 an average home could cost over $1.2 million, and the average car over $65k. But gold could jump to over $12,000 an ounce if it simply stays on the same path that it's been on for two decades. Don’t delay - secure your future before it’s too late.Click here to claim your free kit now Galera Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/16/2023Mark BachledaInsiderBuy11,000$2.25$24,750.00 3/13/2023Chris DegnanCFOBuy10,000$1.96$19,600.00 3/10/2023Mel SorensenCEOBuy100,000$1.68$168,000.00 12/17/2021Linda WestDirectorBuy20,000$2.74$54,800.00 6/15/2021Linda WestDirectorBuy10,000$9.13$91,300.00 6/2/2021Linda WestDirectorBuy10,000$8.65$86,500.00 (Data available from 1/1/2013 forward) GRTX Insider Trading Activity - Frequently Asked Questions Who is on Galera Therapeutics's Insider Roster? The list of insiders at Galera Therapeutics includes Chris Degnan, Linda West, Mark Bachleda, and Mel Sorensen. Learn more on insiders at GRTX. What percentage of Galera Therapeutics stock is owned by insiders? 6.90% of Galera Therapeutics stock is owned by insiders. Learn more on GRTX's insider holdings. Which Galera Therapeutics insiders have been buying company stock? The following insiders have purchased GRTX shares in the last 24 months: Chris Degnan ($19,600.00), Mark Bachleda ($24,750.00), and Mel Sorensen ($168,000.00). How much insider buying is happening at Galera Therapeutics? Insiders have purchased a total of 121,000 GRTX shares in the last 24 months for a total of $212,350.00 bought. More Insider Trading Tools from MarketBeat Related Companies: CMMB Insider Buying GHSI Insider Buying MTEM Insider Buying ERNA Insider Buying TRVN Insider Buying CVKD Insider Buying VIRI Insider Buying MIRA Insider Buying MBRX Insider Buying CYCN Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:GRTX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldGold Set to EXPLODE!Gold Safe ExchangeDoes this make you sick?Allegiance GoldUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalHow Biden has already won 2024Porter & Company348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyUrgent: They're Coming for Your Retirement Money Next!Lear Capital Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.